PT  - JOURNAL ARTICLE
AU  - Wolf-Henning Boehncke
TI  - Dermatologists’ Management of Psoriatic Arthritis: A Report from the 2014 GRAPPA Meeting
AID  - 10.3899/jrheum.150125
DP  - 2015 Jun 01
TA  - The Journal of Rheumatology
PG  - 1029--1031
VI  - 42
IP  - 6
4099  - http://www.jrheum.org/content/42/6/1029.short
4100  - http://www.jrheum.org/content/42/6/1029.full
SO  - J Rheumatol2015 Jun 01; 42
AB  - The presence of concomitant psoriatic arthritis (PsA) directly affects the treatment decisions dermatologists may make as they manage their patients’ psoriasis (PsO). Because the prevalence of PsA increases with PsO duration, it is important to regularly screen for signs and symptoms of PsA. Dermatologists and rheumatologists agree that they need to cooperate in the management of skin and musculoskeletal manifestations of PsA. However, the respective healthcare systems substantially influence how this cooperation is achieved in different countries and possibly even within regions. Some models exist that address how this crucial cooperation can be achieved.